San Diego-based skincare product maker Senté Inc. has raised $2.1 million in Series B financing from a pool of existing and new investors.
Proceeds will help Senté expand its commercial operations, scale development capabilities and grow its product portfolio, the company said in a statement.
Senté, called a “cosmeceutical” company because it melds cosmetics with pharmaceuticals, said in a statement that it’s the only company that uses a compound called heparan sulfate in skin cream. The substance naturally helps with cell regeneration, according to the company.
“We are very pleased to see such strong investor interest in our company from experts in the health care and aesthetic field,” Senté co-founder and board member Kleanthis Xanthopoulos said in a statement. “Our new investors share our vision of creating unique science-based dermatological products that will have profound impacts on the skin, and we very much look forward to working with them on this endeavor.”
— SDBJ Staff Report